Novo Glucagon

DRUG2 trials

Sponsors

Biodel, Xeris Pharmaceuticals

Conditions

HypoglycemiaInsulin HypoglycemiaSevere HypoglycemiaType 1 Diabetes Mellitus

Phase 1

Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons

CompletedNCT02403648

BiodelHypoglycemia

Start: 2014-11-30Updated: 2016-01-15

Phase 3

G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

CompletedNCT03738865

Xeris PharmaceuticalsInsulin Hypoglycemia, Severe Hypoglycemia, Type 1 Diabetes Mellitus

Start: 2018-09-27End: 2019-04-02Updated: 2020-05-22